Are Partin tables suitable for Chinese patients with prostate cancer?

Background: Recently, the number of patients with prostate cancer who needed to be treated with radical prostatectomy increased rapidly in China. There is still a difference between clinical staging and the post-operative final pathologic staging; hence, an excellent tool for accurately predicting the pathologic stages of prostate cancer is needed urgently in clinical practice. The Partin tables are the most popular and widely used tool for predicting the pathologic stages of prostate cancer because of its high accuracy and ease of implementation.

[Flavonoids of puerarin versus tanshinone II A for ischemic stroke: a randomized controlled trial].

Background: Flavonoids are widely used today in the treatment of ischemic stroke. The therapeutic effects and functions of flavonoids are, therefore, generating more and more interest.

Objective: To investigate the therapeutic effects and functions of flavonoids of puerarin in treating patients with ischemic stroke.

[Diagnostic value of lesion-directed prostate biopsy under TRUS in early detection of prostate cancer].

Objective: To evaluate lesion-directed biopsy in improving the detection rate of early prostate cancer (PCa) and in differentiating PCa from other prostate pathological changes.

Methods: We performed TRUS-guided prostate biopsy for 95 patients suspected of PCa, each subjected to extended random biopsy plus lesion-directed biopsy, and analyzed the sonographic characteristics and pathological findings.

Results: PCa was detected in 35 of the patients (36.

Estrogen receptor expression in adrenocortical carcinoma.

Objective: Adrenocortical carcinoma (ACC) is a rare but highly malignant tumor, and its diagnosis is mostly delayed and prognosis is poor. We report estrogen receptor (ER) expression in this tumor and our clinical experiences with 17 ACC cases.

Methods: The data of the 17 patients (9 females and 8 males, age range from 16 to 69 years, mean age of 42.

Androgen receptor expression in clinically localized prostate cancer: immunohistochemistry study and literature review.

Aim: To evaluate androgen receptor (AR) expression in clinically localized prostate cancer (PCa).

Methods: Specimens were studied from 232 patients who underwent radical prostatectomy for clinically localized prostatic adenocarcinoma without neoadjuvant hormonal therapy or chemotherapy at our institution between November 2001 and June 2005. Immunohistochemical study was performed using an anti-human AR monoclonal antibody AR441.